Join Growin Stock Community!

Phreesia, inc.PHR.US Overview

US StockHealthcare
(No presentation for PHR)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

PHR AI Insights

PHR Overall Performance

PHR AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

PHR Recent Performance

-1.09%

Phreesia, inc.

0.05%

Avg of Sector

-0.31%

S&P500

PHR PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

PHR Key Information

PHR Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2026Q1
2026Q2
2026Q3
2026Q4
2027Q1

PHR Profile

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, which are self-service intake tablets; and Arrivals Kiosks that are on-site kiosks. Its Phreesia Platform also provides a registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, and cost estimation tools; access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking; and life sciences solution to deliver targeted and clinically relevant marketing content to patients. In addition, the company's Phreesia Platform offers clinical support solution, which collects clinical intake and patient reported outcome (PRO) data for approximately 25 specialties, as well as enables healthcare services clients to communicate with their patients through surveys, announcements, text and email messaging, and health campaigns; and COVID-19 support modules for managing COVID-19 vaccine delivery and identify vaccine-hesitant patients, screening for self-reported COVID-19 risk factors, enabling contactless check-in during in-person visits, and collecting intake information during telehealth visits. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is headquartered in Raleigh, North Carolina.

Price of PHR

PHR FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

PHR Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-0.09
PE Ratio (TTM)
-
Forward PE
49.08
PS Ratio (TTM)
1.60
PB Ratio
2.32
Price-to-FCF
21.08
METRIC
VALUE
vs. INDUSTRY
Gross Margin
68.20%
Net Margin
-1.16%
Revenue Growth (YoY)
14.33%
Profit Growth (YoY)
16.14%
3-Year Revenue Growth
18.07%
3-Year Profit Growth
21.60%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-0.09
PE Ratio (TTM)
-
Forward PE
49.08
PS Ratio (TTM)
1.60
PB Ratio
2.32
Price-to-FCF
21.08
Gross Margin
68.20%
Net Margin
-1.16%
Revenue Growth (YoY)
14.33%
Profit Growth (YoY)
16.14%
3-Year Revenue Growth
18.07%
3-Year Profit Growth
21.60%

  • When is PHR's latest earnings report released?

    The most recent financial report for Phreesia, inc. (PHR) covers the period of 2026Q3 and was published on 2025/10/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating PHR's short-term business performance and financial health. For the latest updates on PHR's earnings releases, visit this page regularly.

  • What is the operating profit of PHR?

    According to the latest financial report, Phreesia, inc. (PHR) reported an Operating Profit of 3.74M with an Operating Margin of 3.11% this period, representing a growth of 127.01% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is PHR's revenue growth?

    In the latest financial report, Phreesia, inc. (PHR) announced revenue of 120.33M, with a Year-Over-Year growth rate of 12.67%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much debt does PHR have?

    As of the end of the reporting period, Phreesia, inc. (PHR) had total debt of 10.43M, with a debt ratio of 0.02. Short-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.

  • How much cash does PHR have?

    At the end of the period, Phreesia, inc. (PHR) held Total Cash and Cash Equivalents of 106.37M, accounting for 0.25 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does PHR go with three margins increasing?

    In the latest report, Phreesia, inc. (PHR) achieved the “three margins increasing” benchmark, with a gross margin of 68.4%%, operating margin of 3.11%%, and net margin of 3.5%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess PHR's profit trajectory and future growth potential.

  • Is PHR's EPS continuing to grow?

    According to the past four quarterly reports, Phreesia, inc. (PHR)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at 0.07. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of PHR?

    Phreesia, inc. (PHR)'s Free Cash Flow (FCF) for the period is 8.8M, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 449.03% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.

  • What are the PEG ratio and PE ratio of PHR?

    The latest valuation data shows Phreesia, inc. (PHR) has a Price-To-Earnings (PE) ratio of -172.94 and a Price/Earnings-To-Growth (PEG) ratio of 0.13. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.